¿¬¼ö°­ÁÂ
´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ 2019 Pediatric Neurogenetic & Neurometabolic Disease Update : 2019-09-28
´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ 2019 Pediatric Neurogenetic & Neurometabolic Disease Update : 2019-09-28
±³À°ÀÏÀÚ : 2019-09-28
±³À°Àå¼Ò : ÀÌ´ë¼­¿ïº´¿ø ´ë°­´ç  
±³À°ÁÖÁ¦ : 2019 Pediatric Neurogenetic & Neurometabolic Disease Update      
ÁÖÃÖ±â°ü : ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ
´ã´çÀÚ : ¹Ú¹Ì¼±
¿¬¶ôó : 031-219-4522  
À̸ÞÀÏ : ksimd2014@naver.com      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°úÀÇ»çÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í Àü¹®ÀÇ 20,000¿ø/Àü°øÀÇ 10,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-28 ´ë°­´ç 09:00~09:05 Àλ縻  Áøµ¿±Ô(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 09-28 ´ë°­´ç 09:05~09:25 Neurometabolic disorders in children, Introduction  ÀÌÁöÈÆ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 09:25~09:50 Neonatal screening for neurometabolic disorders  ÀÌÁ¤È£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 09:50~10:15 Interpretation and DDx based on routine laboratory tests and metabolic workups  À̹üÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 10:15~10:40 Genetic diagnosis for neurometabolic disorders  ÀÓº´Âù(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 10:40~11:05 Imaging of neuromebabolic disorders  Â÷ÁöÈÆ(¿¬¼¼ÀÇ´ë) 
È޽Ġ09-28 ´ë°­´ç 11:05~11:20 Coffee break  () 
±³À°½Ã°£ 09-28 ´ë°­´ç 11:20~11:40 Emergency treatment for neurometabolic disorders  ÀüÁ¾±Ù(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 11:40~12:00 Diet therapy for neurometabolic disorders  ±èÀ¯¹Ì(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 12:00~12:20 Therapeutic strategies for lysosomal storage disorders  Á¶¼ºÀ±(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 12:20~12:40 Gene therapy for neurometabolic disorders  Á¤¼ºÃ¶(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 12:40~13:00 Cell therapy for neurometabolic disorders  Çѽ¹Î(¿¬¼¼ÀÇ´ë) 
½Ä»ç 09-28 ´ë°­´ç 13:00~14:00 Lunch  () 
±³À°½Ã°£ 09-28 ´ë°­´ç 14:00~14:25 Metabolic Evaluation of Epilepsy: A Diagnostic Algorithm With Focus on Treatable Conditions  °í¾Æ¶ó(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 14:25~14:50 Final hope for neuronal ceroid lipofuscinosis? Novel treatment targets and strategies  º¯Á¤Çý(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 14:50~15:15 Approach to adrenoleukodystrophy and current management guidelines and prospects  °­ÈÆö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 15:15~15:40 Genetic diagnosis and management of mitochondrial disorders  ÀÌ¿µ¸ñ(¿¬¼¼ÀÇ´ë) 
È޽Ġ09-28 ´ë°­´ç 15:40~16:00 Coffee break  () 
±³À°½Ã°£ 09-28 ´ë°­´ç 16:00~16:25 Overview of acid sphingomyelinase deficiency (ASMD)  ¼Õ¿µ¹è(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 16:25~16:50 Glutaric aciduria, proposed recommendations for diagnosis and management  ±è¼öÁø(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 16:50~17:15 Dopa-responsive dystonia with different causes  ¿°¹Ì¼±(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-28 ´ë°­´ç 17:15~17:40 Treatable metabolic myopathies  °íÁ¤¹Î(¼­¿ïÀÇ´ë) 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,657 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,712 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-16

±³À°ÀÏÀÚ : 2024-03-16 ±³À°Àå¼Ò : ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,708 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼¼ºê¶õ½ºº´¿ø 2018 ¼¼¸ñȸ Çмú´ëȸ : 2018-11-10

±³À°ÀÏÀÚ : 2018-11-10 ±³À°Àå¼Ò : °­³² ¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : 2018 ¼¼¸ñȸ Çмú´ëȸ ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú ´ã´çÀÚ : ¹Ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,392 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,398 , ´ñ±Û¼ö : 0